# Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer?

> **NCT03543215** · — · UNKNOWN · sponsor: **Imperial College London** · enrollment: 500 (estimated)

## Conditions studied

- Endometrial Cancer
- Endometrial Neoplasms

## Interventions

- **OTHER:** Radiomics: Analysis of textural features of imaging (MRI and Ultrasound)

## Key facts

- **NCT ID:** NCT03543215
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-13
- **Primary completion:** 2021-12-10
- **Final completion:** 2025-12-10
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2021-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03543215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03543215, "Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer?". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT03543215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*